Corporate News
Grant of Options
14 October 2022
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that share options (“Options”) over 16,000,000 ordinary shares of the Company have been granted to the Executive Directors under the 2016 EMI Share Option Scheme at an exercise price of 1.6p per share (being the closing price of the shares on 13 October 2022) as detailed below:
Name of Director | Number of Options Granted |
---|---|
Penelope McCormick, CEO | 10,000,000 (Unapproved) |
Nicholas Edwards, CFO | 6,000,000 |
For both Executive Directors, the Options will vest in three equal tranches on 13 October 2023, 13 October 2024 and 13 October 2025. Each option is exercisable into one ordinary share and once vested, can be exercised up until 13 October 2032.
These new options represent approximately 2.05 per cent of the Company's current issued share capital. In total 42,084,600 options are now outstanding, representing approximately 5.39 per cent of the Company's current issued share capital.
For further information contact:
MyHealthChecked plc | www.myhealthchecked.com | |
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
Nicholas Edwards, Chief Financial Officer | ||
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | [email protected] | |
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Anna Dunphy | Mob: +44(0)7876 741 001 | |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests, supported by a user-friendly digital interface..
MyHealthChecked is the umbrella brand of a range of at-home wellness tests that are available online, and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Penelope McCormick | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | MyHealthChecked PLC | ||||
b) | LEI | 213800RBHY6LZDG13168 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.1p each
GB00BYZ2R301 | ||||
b) | Nature of the transaction | Grant of share options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
|
n/a | ||||
e) | Date of the transaction | 13 October 2022 | ||||
f) | Place of the transaction | Off market transaction |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Nicholas Edwards | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Financial Officer | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | MyHealthChecked PLC | ||||
b) | LEI | 213800RBHY6LZDG13168 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.1p each
GB00BYZ2R301 | ||||
b) | Nature of the transaction | Grant of share options | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
|
n/a | ||||
e) | Date of the transaction | 13 October 2022 | ||||
f) | Place of the transaction | Off market transaction |